Alliance News
 
Working Together
 
Welcome
A Fast, Focused Approach
Alliance Management
What We Are Looking For
 
Doing Our Part

 



 

  » BMS.com Home » Alliances » Working Together » Alliance Management.
 
 



 

Alliance Management.

How do you maximize the commercial asset?

Alliance Management focuses on what is best for the asset. Members of the group are experienced business people whose primary role is to "shadow" the development and commercial relationship, build and maintain alignment, and keep the asset moving forward.

Finding the right process.

Alliance Management includes oversight of governance activities, ensuring that the governance team works smoothly to make joint decisions and implement those decisions effectively -- and transparently.

The group is also responsible for conflict resolution, helping in fast resolution of difficult issues to keep the partnering process and the asset moving forward -- avoiding "no decision" situations. It also allows the other members of the team to focus on their role in implementation of development, registration, manufacturing, and commercialization.

Our process provides ongoing opportunities for communication and sharing information, including routine contact with partners and regular contact with key stakeholders within Bristol-Myers Squibb, such as the Commercial, Clinical, Regulatory, and Manufacturing groups. We also apply technology to streamline communication, including extranet websites for data sharing and exchange. In short, our process represents our unrelenting focus on maximizing the asset and the relationship.

Alliance Management Diagram



[Top Page] [Search] [Index] [Contact] [Home]

Italicized product names are trademarks of Bristol-Myers Squibb Company or one of its divisions or subsidiaries. Abilify is a trademark of Otsuka Pharmaceutical Co., Ltd. Atripla is a trademark of Bristol-Myers Squibb & Gilead Sciences, LLC. Erbitux is a trademark of ImClone Systems Incorporated. EMSAM is a trademark of Somerset Pharmaceuticals, Inc. Glucophage, Glucovance and Metaglip are trademarks of Merck Santé S.A.S., an associate of Merck KGaA of Darmstadt, Germany. Avapro, Avalide and Plavix are trademarks of sanofi-aventis. Sinemet CR is a trademark of Merck & Co., Inc.

© 1999-2008 Bristol-Myers Squibb Company. Your use of the information on this site is subject to the terms of our Legal Notice and Privacy Policy.

 

SEARCH INDEX